Treatment Challenges In Acral And

Yana Najjar, MD, UPMC Hillman Cancer Center, Pittsburgh, PA, describes the

Karijn Suijkerbuijk, MD, PhD, UMC Utrecht, Utrecht, The Netherlands, discusses the management of immunotherapy related ...

Yasuhiro Nakamura, MD, PhD, Saitama Medical University International Medical Center, Saitama, Japan, discusses the ...

Dive into a critical conversation about

Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, discusses

Acral

Join us for an Ask the Expert session focused on

AIM at Melanoma is proud to host this virtual event on Tuesday, January 13th, from 5:30 – 7:00 PM ET, featuring top melanoma ...

In this informative session, Dr. Allison Betof Warner, Assistant Professor of Medicine/Oncology at Stanford University School of ...

Karijn Suijkerbuijk, MD, PhD, UMC Utrecht, Utrecht, The Netherlands, discusses

Dr Teresa Amaral discusses considerations for avoiding

Teresa Amaral explores the evolving landscape of immunotherapy in the adjuvant setting for patients diagnosed with melanoma.

In this session, Dr. Meredith McCain, a leading clinical trialist in advanced melanoma, discusses the latest developments in ...

Not only is it possible to get relief from worries about Ocular Melanoma, but it is also possible for you to become an expert, to take ...

Hematologic malignancies are cancers that affect the blood, bone marrow, and lymph nodes. This classification includes both the ...

On Thursday, November 13, the Melanoma Research Alliance (MRA) hosted an MRA Meet Up webinar, moderated by MRA's ...

Join Dr. Vince Ma, medical oncologist at the University of Wisconsin Carbone Cancer Center, as he presents the latest advances ...

Summary In this conversation, Sapna Patel and James Larkin discuss the Checkmate 238 landmark study on adjuvant

Melissa Wilson, PA-C, MPAS and Melanoma Lead at UPMC, explains Melanoma Stage 0, sometimes referred to as 'melanoma in ...

Are you or a loved one navigating the